SCHEMBL7908797

SCHEMBL7908797

CC(=NOC(=O)c1ccccc1)OC(=O)[C@@H](N)CCCCNOC(=O)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
MAPT P10636 4/20 0.36
CDK5 Q00535 3/20 0.36
CDK5R1 Q15078 3/20 0.36
PKM P14618 3/20 0.36
TNF P01375 1/20 0.36
KLF5 Q13887 1/20 0.36
NOD1 Q9Y239 1/20 0.36
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
MITF O75030 1/20 0.34
RBBP9 O75884 1/20 0.34
DPP7 Q9UHL4 2/20 0.33
DPP8 Q6V1X1 1/20 0.33
XDH P47989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7911821 0.85 ALDH1A1 (0.38) MAPTALDH1A1POLBKMT2ADPP7
SCHEMBL18596826 0.83 KIF11 (0.43) MAPTALDH1A1POLBKMT2ADPP7
SCHEMBL18402487 0.79 POLB (0.46) MAPTALDH1A1POLBKMT2ADPP7
SCHEMBL8821866 0.79 PLA2G7 (0.38) MAPTALDH1A1POLBKMT2ADPP7
SCHEMBL7909560 0.77 NOS2 (0.32) KMT2ADPP7
SCHEMBL7908794 0.76 C3AR1 (0.41) SMN1; SMN2MAPTCDK5CDK5R1PKM
SCHEMBL7220224 0.76 METAP2 (0.36) POLBKMT2ADPP7DPP8
SCHEMBL7224733 0.75 TDP1 (0.36) SMN1; SMN2ALDH1A1KMT2ADPP7DPP8
SCHEMBL7218266 0.75 NOS2 (0.31)
SCHEMBL7218362 0.74 DPP8 (0.41) NPC1RAB9AALDH1A1DPP7DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US disclosed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP disclosed